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I. INTRODUCTION
The field of intellectual property (IP) law refers generally to the law of
trademarks, patents, copyrights and trade secrets. Each area of IP gives the owner
different rights and is directed to particular subject matter, though some overlap
occurs. Trademark law protects anything that may serve to identify a source of
goods or services,' but protection does not extend to anything functional.2 Patent law
protects novel and useful compositions of matter, machines, articles of manufacture
and processes,3 that is, functional items. Copyright law protects "original works of
authorship,",4 and expressly excludes discoveries, ideas, and processes from its
ambit.5 Trade secret law protects information that is valuable because of its secret
nature.6 The cost to obtain each type of protection may also differ radically; the
government fees are $325 to file a trademark application,7 $710 to file a patent
application,8 and $30 to register a copyright. 9 The government charges nothing for
trade secret protection; the cost of such protection entails an amount necessary for
"efforts that are reasonable under the circumstances to maintain [the secret's]
I. See 15 U.S.C.A. § 1127 (West Supp. 2000) (defining "trademark" and "service mark").
2. See, e.g., Keene Corp. v. Paraflex Indus., Inc., 653 F.2d 822, 824 (3d Cir. 1981) ("One of the essential
elements of the law of trademarks.., was the principle that no legal protection would be available for products or
features that were functional .... ").
3. See 35 U.S.C.A. § 101 (West 1984) (defining the scope of patentable subject matter). All references to
patents in this Comment are directed to utility patents. Design patents, id. §§ 171-173 (West 1984 & Supp. 2000),
and plant patents, id. §§ 161-164 (West 1984 & Supp. 2000), are outside the scope of this Comment.
4. 17 U.S.C.A. §§ 102(a) (West 1996) (defining the subject matter of copyright). Similar protection is
available for semiconductor chips and mask works. See id. §§ 901-914 (West 1995).
5. Id. § 102(b) (West 1996).
6. See Uniform Trade Secrets Act, CAL. CIV. CODE § 3426.1(d)(1) (West 1997) (defining "trade secret").
The formula for Coca-Cola is a famous example of information protected by trade secret law.
7. 37 C.F.R. § 2.6(a)(1) (2000).
8. Id. § 1.16(a). But see id. § 1.9(f) (defining a small entity); id. § 1.16 (allowing reduced fees for those
inventors having small entity status).
9. Id. § 201.3(c).
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secrecy."' When seeking to protect intellectual property, one must evaluate the
types of protection available and select that which would be most valuable. In
addition to the initial cost of obtaining IP protection, the cost of enforcing one's
rights is a significant consideration. If enforcement costs are prohibitive, obtaining
protection is useless.
Patent law offers the most extensive protection, but the requirements are more
stringent than in the other IP disciplines and the examination procedure is much
more involved." The protection obtained by a patent, however, is limited in time.
12
Inventors are encouraged to effectively license or market their inventions to offset
the high costs of patenting. This Comment examines several patents and their
prospects for enforcement as an evaluation of their economic worth. 13 If there is no
practical way to enforce a patent, the opportunities for realizing economic value are
severely curtailed. Part II provides an overview of patent law requirements and
patent examination procedure, as well as the advantages and disadvantages of
obtaining a patent. Part III addresses five patents that have been granted by the
Patent and Trademark Office (PTO), detailing their prosecution history and
evaluating their prospects for economic viability. Part IV explores certain patents
obtained by researchers at Johns Hopkins University-the lawsuit that spawned
from these patents demonstrates that seemingly unenforceable patents may find life
if the right defendant is identified. These patents are also indicative of the outer
limits of patent protection, perhaps even crossing the line of impermissibility. This
Comment concludes with an evaluation of the conflict between examination
procedure policy and the interest of the public in the patent system.
II. PATENT LAW
American patent law has its foundation in English common law, in which the
Crown had the power to issue patents. 14 In America, one finds the basis of the patent
statutes in the Constitution: "The Congress shall have Power ... To promote the
Progress of Science and useful Arts, by securing for limited Times to... Inventors
10. See Uniform Trade Secrets Act, CAL. CIv. CODE § 3426.1(d) (defining "trade secret").
1I. Compare 17 U.S.C.A. § 102 (West 1996) ("Copyright protection subsists ... in original works of
authorship ....") with 35 U.S.C.A. §§ 100-212 (West 1996) (setting forth the rigorous requirements for both
patentability and examination of patent applications).
12. See 35 U.S.C.A. § 154(a)(2) (West Supp. 2000) (granting the right to exclude for a term of twenty years
from the filing date of the original application). Patents granted before June 8, 1995, were subject to a term of
seventeen years from the date of the patent's issue.
13. Enforcement of patents is not a consideration of the United States Patent and Trademark Office (PTO).
This Comment does not suggest that it should be; it merely looks to enforcement as a measure of economic viability
with respect to specific patents. As an aside, it suggests that certain patents are, or should be, outside the realm of
permissible subject matter.
14. See generally Michael D. Davis, The Patenting of the Products of Nature, 21 RUTGERS COMPUTER &
TECH. L.J. 293, 298 (1995).
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the exclusive Right to their respective ... Discoveries .... ,,'5 The patent statutes
grant the owner of the patent the right to exclude others from making, using, or
selling the invention. 6 These rights are granted in exchange for full disclosure of
how to make and use the invention, and the best mode of doing so."
A. Patentable Subject Matter
To obtain a patent, one must have statutory subject matter. The requirements for
statutory subject matter are threefold: the invention must be useful, 8 novel,' 9 and
nonobvious.2° In addition to the requirement of statutory subject matter, an inventor
must disclose how to make and use the invention 21 and the best mode of practicing
the invention known to the inventor at the time the invention was made. 2
The usefulness, or utility, requirement is met when the applicant shows that the
invention operates and has a practical use. 23 The novelty requirement means that the
invention must not be "anticipated '24 by the prior art,2 5 either in the form of a
15. U.S. CONST, art. I, § 8, c1. 8. Many consider Thomas Jefferson "the father of the American patent
system." Edward C. Walterscheid, Patents and the Jeffersonian Mythology, 29 J. MARSHALL L. REV. 269, 269
(1995) (reviewing Jefferson's writings on patents).
16. 35 U.S.C.A. § 154(a)(1) (West Supp. 2000).
17. Id. § 112 (West 1984).
18. Id. § -101 (West 1984) ("Whoever invents or discovers any new and useful process, machine,
manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor,
subject to the conditions and requirements of this title."). For a discussion of standards used to determine utility,
see generally Andrew T. Kight, Note, Pregnant with Ambiguity: Credibility and the PTO Utility Guidelines in Light
of Brenner, 73 IND. L.J. 997,(1998) (evaluating the lowering of the utility standard from "substantial utility" to
"credible utility").
19. Id. § 102 (West 1984 & Supp. 2000).
20. Id. § 103 (West Supp. 2000).
21. Id. § 112 (requiring an enabling disclosure).
22. Id. (requiring disclosure of the best mode of practicing the invention).
23. See Bedford v. Hunt, 3 F Cas. 37, 37 (C.C.D. Mass. 1817) (No. 1217) ("The law ... simply requires,
that [the invention] shall be capable of use ...."). A guarantee of utility is not necessary; a potential for utility is
sufficient. Cf Exparte McKay, 200 U.S.P.Q. 324, 325-26 (PTO Bd. App. 1975) (concluding that a method for
"obtaining oxygen from extraterrestrial materials" met the utility requirement, even though it was not useful on
earth). Similarly, an invention need not be complicated to qualify for patent protection. See, e.g., Bedford, 3 F. Cas.
at 37 ("The law... does not look to the degree of utility .... ); Earle v. Sawyer, 8 E Cas. 254, 256 (C.C.D. Mass.
1925) ("It is of no consequence, whether the thing be simple or complicated .... ); Goodyear Tire & Rubber Co.
v. Ray-O-Vac Co., 321 U.S. 2 7 5, 2 79 (1944) ("[T]he means.., seem simple.. .but this is not enough to negative
invention."); Panduit Corp. v. Dennison Mfr. Co., 810 F.2d 1561, 1572 (Fed. Cir. 1987), cert. denied, 481 U.S. 1052(1987) ("The statute requires utility, novelty, and nonobviousness, not complexity."); In re Oetiker, 977 F.2d 1443,
1447 (Fed. Cir. 1992) ("Simplicity is not inimical to patentability.").
24. Anticipation requires that the all aspects of the applicant's invention be disclosed in a single reference,
that is, a single patent, patent application, or printed publication. RCA Corp. v. Applied Digital Data Sys., Inc., 730
F.2d 1440, 1444 (Fed. Cir. 1984), cert. dismissed sub nom. Hazeltine Corp. v. RCA Corp., 468 U.S. 1228 (1984).
25. "Prior art is knowledge that is available, including what would be obvious from it, at a given time, to
a person of ordinary skill in the art." ROBERT L. HARMON, PATENTS AND THE FEDERAL CIRCUIT 11 (3d ed. 1994).
See Environmental Designs, Ltd. v. Union Oil Co., 713 F.2d 693, 696-97 (Fed. Cir. 1983) (listing factors relevant
to determining the level of ordinary skill in the art). See generally MAN. PAT. EXAM. PROC. §§ 901.01-901.09 (7th
ed. Revision No. 1, 2000) (setting forth the types of references that may be used as prior art during examination of
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publication 26 or another patent or patent application, 27 and that the invention has not
been "in public use or on sale in this country[] more than one year prior" to the
filing date of the application. 28 Not all new and useful inventions, however, are
entitled to patent protection. A new invention "may still not be patentable if the
differences between the new thing and what was known before is not considered
sufficiently great to warrant a patent. '29 This third test, an obviousness
determination, is neither well-defined nor simple to understand. 30 During the 1952
revisions to the Patent Act, Congress' evident intent was to define the scope of
statutory subject matter as broadly as possible. In fact, the records of the House and
Senate hearings contain a remark that "anything under the sun that was made by
man" may be statutory subject matter.31 In 1980, however, Chief Justice Burger
explicitly stated that "[t]his is not to suggest that §: 101 has no limits or that it
embraces every discovery. The laws of nature, physical phenomena, and abstract
ideas have been held not patentable."32
Whether products of nature may be patented continues to be a source of
controversy. 33 For example, a patent claim for a naturally-occurring fiber in the
applications) [hereinafter MPEP].
26. See 35 U.S.C.A. § 102(a), (b) (West 1984 & Supp. 2000) (referring to foreign and domestic printed
publications).
27. See id. § 102(d), (e) (regarding foreign and domestic patents and applications for patents).
28. Id. § 102(b).
29. In re Bergy, 596 F.2d 952, 962 (C.C.P.A. 1979), rev'd on other grounds, Diamond v. Chakrabarty, 447
U.S. 303 (1980).
30. See generally George M. Sirilla & Honorable Giles S. Rich, 35 U.S.C. § 103: From Hotchkiss to Hand
to Rich, the Obvious Patent Law Hall-of-Famers, 32 J. MARSHALL L. REV. 437 (1999). The Patent Act of 1952 made
nonobviousness a statutory requirement and explicitly stated that "[p]atentability shall not be negatived by the
manner in which the invention was made." 35 U.S.C.A. § 103(c) (West Supp. 2000). This wording was a response
to historical treatment and conflict regarding the threshold of patentability, which included the rise and fall of the
"flash of genius" test. See, e.g., Earle v. Sawyer, 8 F. Cas. 254, 256 (C.C.D. Mass. 1825) ("It is of no
consequence... whether it be by accident, or by long laborious thought, or by an instantaneous flash of mind, that
[the invention] is first [made]. The law looks to the fact, and not to the process by which it is accomplished.");
Hotchkiss v. Greenwood, 52 U.S. 248,267 (1850) (requiring greater "ingenuity" than that of a "skillful mechanic");
Cuno Eng'g Corp. v. Automatic Devices Corp., 314 U.S. 84, 91 (1941) ("[T]he new device, however useful it may
be, must reveal the flash of creative genius not merely the skill of the calling."). The tension was resolved in
Graham v. John Deere Co.:
It is undisputed that [35 U.S.C.A. § 103] was, for the first time, a statutory expression of an additional
requirement for patentability, originally expressed in Hotchkiss. It also seems apparent that Congress
intended by the last sentence of § 103 to abolish the test it believed this court announced in the
controversial phrase "flash of creative genius," used in Cuno Corp. v. Automatic Devices Corp., 314
U.S. 84, 51 USPQ 272 (1941).
383 U.S. 1, 15 (1966).
31. S. REP. No. 82-1979 at 5 (1952); H.R. PrP. No. 82-1923 at 6 (1952) ("A person may have 'invented'
a machine or manufacture, which may include anything under the sun that is made by man, but it is not necessarily
patentable under section 101 unless the conditions of the title are fulfilled.").
32. Diamond v. Chakrabarty, 447 U.S. 303, 309 n.6. (citations omitted).
33. See generally Davis, supra note 14 (providing a history of patent law and addressing its application to
biotechnology); Stephen McKenna, Comment, Patentable Discovery?, 33 SAN DIEGo L. REV. 1241 (1996) (utilizing
an example similar to the situation examined in Part IV of this Comment).
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needle of the Pinus australis tree was rejected, and the Commissioner of Patents
affirmed the rejection:
It cannot be said that the applicant in this case has made any discovery, or
is entitled to patent the idea, or fact, rather, that fiber can be found in the
needle of the Pinus australis, or that it is a longer fiber than can be found in
other leaves, or that it possesses more or less strength of fineness, because
the mere ascertaining of the character or quality of trees that grow in the
forest and the construction of the woody fiber and tissue of which they are
composed is not a patentable invention, recognized by the statute, any more
than to find a new gem or jewel in the earth would entitle the discoverer to
patent all gems which should be subsequently found .... The result would
be that ... patents might be obtained upon the trees of the forest and the
plants of the earth, which of course would be unreasonable and
impossible. 4
Similarly, applications claiming natural elements were rejected, because natural
elements are products of nature. 35 Man-made elements, on the other hand, are not
products of nature, and patents were accordingly granted.36 Patents have been
allowed for purified versions of not only artificial compounds,37 but also natural
compounds. 8 The rationale for allowing patents on purified natural products is that
the pure form is not known to exist in nature, so production of a purified form is
therefore "novel. 39 Methods drawn to new uses for old compounds have been held
patentable, but old compounds do not necessarily become "novel" when such a new
use is discovered absent a surprisingly unexpected benefit.40
34. In re Bergy, 596 F.2d 952,982-83 (C.C.P.A. 1979) (citing Exparte Latimer, 1889 C.D. 123, 125, cert.
granted, 444 U.S. 924 (1979), dismissed as moot, 444 U.S. 1028 (1980)).
35. See, e.g., In re Marden, 47 F.2d 957, 957 (C.C.P.A. 1931) (uranium); In re Marden, 47 F.2d 958, 959
(C.C.P.A. 1931) (vanadium); General Electric Co. v. DeForest Radio Co. et al., 28 F.2d 641, 643 (3d Cir. 1928)
(tungsten), cert. denied, 278 U.S. 656 (1929).
36. See, e.g., In re Seaborg, 328 F.2d 996, 999 (C.C.P.A. 1964) (americium); In re Seaborg, 328 F.2d 993,
995 (C.C.P.A. 1964) (curium).
37. E.g., Kuehmsted v. Farbenfabriken of Elberfeld Co., 179 F. 701, 705 (7th Cir. 1910) (aspirin), cert.
denied, 220 U.S. 622 (1911).
38. See, e.g., In re Bergstrom, 427 F.2d 1394, 1402 (1970) (prostaglandins); Merck & Co. v. Olin Matheson
Chem. Corp., 253 F.2d 156, 164 (Fed. Cir. 1958) (vitamin B12-active compositions); Rebecca S. Eisenberg, Re-
examining the Role of Patents in Appropriating the Value of DNA Sequences, 49 EMORY L.J. 783, 785-86 (2000)
(DNA sequences).
39. Bergstrom, 427 F.2d at 1240.
40. See In re May, 574 F.2d 1082, 1090 (C.C.P.A. 1978) ("While appellants have discovered a hitherto
unknown property [of the prior art compound] ... such discovery does not constitute a new use."). In May, the
applicants discovered that a prior art compound known to be an analgesic was also nonaddictive. Id. at 1089. See
also Titanium Metals Corp. v. Banner, 778 F.2d 775, 782 (1985) ("Congress has not seen fit to permit the patenting
of an old alloy ... by one who has discovered its corrosion resistance or other useful properties ....").
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The landmark case of Diamond v. Chakrabarty" discussed whether 35 U.C.S.A.
§ 101 encompasses living material, and peripherally discussed the patenting of
products of nature.42 Chakrabarty involved a patent on a strain of bacteria that had
been genetically-engineered to break down crude oil, making it useful in the cleanup
of oil spills. 43 The PTO and the court below found the invention not within the
parameters of the statute because (1) bacteria are "products of nature," and (2)
patents could not be obtained on living organisms." The Supreme Court disagreed,
finding that the bacteria were man-made; such an organism was not found in nature
(at least, in concentrated "purified" form), 45 and the fact that the organism was
"alive" had no bearing.46 The determination that living things are within statutory
subject matter continues to the present day.
47
B. Examination Procedure
Patent applications are prosecuted, or examined, before the PTO.49 While an
application may be prosecuted by an inventor who is not a patent practitioner,50 an
inventor should appoint a patent practitioner to prosecute the application in the
inventor's name. 5' The practitioner prepares a patent application based on
information about the invention that the inventor provides. The application contains
the following parts: (1) a title, (2) cross references to related applications, (3) a
statement if the invention is the product of federally-sponsored research, (4) a
background, (5) a summary, (6) a brief description of the drawings, (7) a detailed
description of the preferred embodiment, (8) claims directed to the invention, and
41. 447 U.S. 303 (1980).
42. Id. at 306, 309.
43. id. at 305.
44. Id. at 306.
45. Id. at 310 ("His discovery is not nature's handiwork ... .
46. Id. at 313. The Court determined that if Congress wanted to exclude living things, it would have
expressly done so. Id. at 318. See, e.g., 42 U.S.C.A. § 2181 (a) (West 1994) (excluding atomic energy utilized in an
atomic weapon from the scope of patent protection).
47. See, e.g., U.S. Patent No. 4,736,866 (issued Apr. 12, 1988) (protecting the "Harvard mouse," a
genetically altered mouse that is susceptible to cancer); Pioneer Hi-Bred Int'l Inc. v. J.E.M. Ag Supply, Inc., 200
F.3d 1374, 1378 (2000) (finding seeds and seed-grown plants patentable under 35 U.S.C.A. § 101).
48. In patent law, prosecution is a term of art, referring to the process that begins when a patent application
is filed and ends when the application is abandoned or when a patent issues. See BLACK'S LAW DICTIONARY 1237
(7th ed. 1999) (defining prosecution history as "[t]he complete record of proceedings... from the initial application
to the issued patent.").
49. See generally 35 U.S.C.A. §§ 131-135 (West 1984 & Supp. 2000).
50. A patent practitioner is one who has been registered to practice in front of the Patent and Trademark
Office, as either a Patent Agent or a Patent Attorney. 37 C.F.R. § 10.1(r) (2000). One need not be an attorney to
meet the registration requirements of the PTO. Id. § 10.6.
51. In the United States, patent applications must be filed in the name of the inventor or inventors. See 35
U.S.C.A. § 11 l(a)(l) (West Supp. 2000) ("application for patent shall be made ... by the inventor"); id. § 116
(West Supp. 2000) (regarding joint inventors); id. § 117 (West 1984) (concerning death or incapacity of inventors);
id. § 118 (West Supp. 2000) (addressing the situation when an inventor cannot be located or refuses to sign).
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(9) an abstract.52 The specification must contain enough information to support the
invention disclosed in the claims.53 When the application is filed, its priority with
respect to other applications is based on its filing date.54 While the application may
be amended after filing, no new matter may be added.55
After the inventor approves the application, the application is filed with the
PTO. The PTO opens a new file wrapper16 and assigns it to an examining group.17
The application is assigned to an examiner, who determines whether the application
contains statutory subject matter, whether that subject matter is entitled to a patent,
and whether the other application requirements are met.58 If the examiner believes
that the application contains more than one invention, the examiner may issue a
restriction requirement, dividing the claims into groups and requiring that a subset
of the groups of claims be prosecuted. 59 The claims that are not prosecuted may be
prosecuted in a separate application, called a divisional application. 60 If a restriction
requirement is not appropriate, the examiner then conducts a search of the prior art,
evaluates the application in light of the results, and prepares and sends an Office
Action to the patent practitioner.6' The Office Action specifies those claims in the
application the examiner will and will not allow. 62 Allowance of claims is generally
considered with reference to the prior art that the examiner locates. Rejection of a
claim indicates that the subject matter of the claim is not patentable. 63 Claims may
be rejected for anticipation or lack of novelty.64 To reject claims on the basis of
52. MPEP, supra note 25, at §§ 601, 608.01(a).
53. The specification includes the written description of how to make and use the invention and the best
mode known to the inventor of practicing the invention. MPEP, supra note 25, at § 608.01. The claims define the
scope of the patent. See generally MPEP, supra note 25, at § 608.01 (i)-(o) (establishing the requirement and form
of the claims).
54. See generally MPEP, supra note 25, at § § 201.11-201.16 (recognizing a right of priority). This scenario
assumes that no applications for foreign patents have been filed regarding this invention. Priority may be obtained
for some foreign applications, awarding the U.S. application the benefit of the foreign filing date. 35 U.S.C.A.
§ 119(a) (West Supp. 2000).
55. MPEP, supra note 25, at § 706.03(o). "Any effort to define new matter is hopeless. It is more useful
simply to say that an amendment that conforms the written specification to the original drawing or claims, or that
clarifies something inherent in the original disclosure, does not introduce new matter." HARMON, supra note 25,
at 160-61.
56. The file wrapper contains all papers related to the prosecution of the application. MPEP, supra note 25,
at § 719.
57. MPEP, supra note 25, at § 504. Examiners in the PTO are parceled out into examining groups; each
group examines applications relevant to a particular art. See MPEP, supra note 25, at § 903.08 (allowing primary
examiners "to accept any application submitted to them that they believe is properly classifiable in a class in their
art unit").
58. See 35 U.S.C.A. § 112 (West 1984) (requiring a written description of the invention, an enabling
disclosure and disclosure of the best mode known to the inventor of practicing the invention).
59. Id. § 121 (West Supp. 2000). See generally MPEP, supra note 25, at ch. 800 (focusing on restriction
practice).
60. 35 U.S.C.A. § 121; MPEP, supra note 25, at § 201.06 (regarding division applications).
61. 37 C.ER. § 1.104(a)(l)-(2) (2000).
62. Id. § 1.104; MPEP, supra note 25, at § 707.
63. See generally MPEP, supra note 25, at § 706 (regarding rejections of claims).
64. 35 U.S.C.A. § 102 (West 1984 & Supp. 2000).
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anticipation, the examiner must cite one reference that contains each and every
element of the claimed invention in the application.65 Claims may also be rejected
for obviousness. 66 If the examiner rejects claims for obviousness, the examiner may
combine references to cite against the application.67 An objection, rather than a
rejection, is issued if only the form of a claim is improper.68
The patent practitioner consults with the inventor regarding the Office Action
and files an amendment in response to the Office Action. Each ground the examiner
raises must be addressed or the response will be deemed incomplete and the
application held abandoned.69 The response may cancel or amend claims to comply
with requirements that the examiner has made or to distinguish over the cited prior
art, or it may add entirely new claims.70 In addition, the practitioner includes
remarks that point out inaccuracies by the examiner, acquiesce in the examiner's
determinations, or introduce new issues into the process by adding new claims to the
application. The practitioner must file the reply within the statutory six-month
period for response, or the application is considered abandoned.7'
Communication between the practitioner and the examiner continues until the
examiner allows all of the claims, the practitioner appeals a non-final second Office
Action, or the examiner issues a final rejection.72 After the examiner issues a final
rejection, the practitioner may file an amendment to put the application in position
for issue, but entering this amendment is subject to the examiner's discretion. 73 If
no claims in the application are passed to issue, the practitioner may appeal the
examiner's rejection or file a continuation application, which begins another round
65. MPEP, supra note 25, at § 2131.
66. 35 U.S.C.A. § 103 (West Supp. 2000).
67. MPEP, supra note 25, at § 706.02(j) ("35 U.S.C. 103 authorizes a rejection where.., it is necessary to
modify a single reference or to combine it with one or more references."). For instance, if all of the elements of the
claimed invention except one are found in reference A, and the missing element is found in reference B, the
examiner will reject the claims as unpatentable over A in view of B. If, in fact, the state of the art at the time the
invention was made was such that one skilled in the art would have found it obvious to combine these references,
then the obviousness standard is not met, and the invention is not patentable. Hindsight is not permissible in an
obviousness determination. 35 U.S.C.A. § 103(a) ("at the time the invention was made"); In re Oetiker, 977 F.2d
1443, 1447 (Fed. Cir. 1992) ("There must be some reason, suggestion, or motivation found in the prior art whereby
a person of ordinary skill in the field of the invention would make the combination. That knowledge cannot come
from the applicant's invention itself.").
68. MPEP, supra note 25, at § 706.01. One must petition the Commissioner of Patents for review of
objections. Id.
69. MPEP, supra note 25, at §§ 711.02, 711.02(a) (regarding insufficient replies).
70. 35 U.S.C.A. § 133 (West 1984). There must be support in the specification for the new claims to retain
the benefit of the priority date from the filing. See also, supra note 25, at § 2163.06 ("If new matter is added to the
claims, the examiner should reject the claims .... "); supra note 55 (regarding new matter).
71. MPEP, supra note 25, at § 710.01. The examiner usually sets a three-month, shortened statutory period
for response to Office Actions. MPEP, supra note 25, at § 710.02(b). If a response is filed between three and six
months, the applicant must file a petition for extension of time and submit the appropriate fee. MPEP, supra note
25, at § 710.02(e). See also MPEP, supra note 25, at §§ 711-711.05 (regarding abandonment of applications).
72. MPEP, supra note 25, at § 706.07.
73. See MPEP, supra note 25, at § 714.13 (noting that entry of such an amendment is not a matter of right).
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of the process.74 If some claims are passed to issue, the practitioner may file a
continuation or divisional application that includes rejected claims and non-elected
claims, and the process continues for those claims. Generally, continuation and
divisional applications retain the benefit of the filing date of the original
application.75
Applicants may request interviews with the examiner to discuss patentability of
the invention; such interviews may take place by telephone, in person, or by
electronic mail.76 If prior art relevant to the application is discovered after filing, the
references must be added to the file wrapper by filing them with an Information
Disclosure Statement (IDS).77 If the examiner decides that the applicant is entitled
to a patent, a Notice of Allowability is sent, requiring payment of an issue fee before
the patent issues.78
The PTO has issued over six million patents since 1790.79 Clearly, we are in a
patent boom, as increasing numbers of patents are issued each year.80 The five
millionth patent was issued in 1990 and the six millionth issued in 1999.81 Advances
in technology, especially biotechnology and computer science, have played a
significant role in the proliferation of patents, but perhaps such advances are not the
only reason.
C. Advantages and Disadvantages of Patenting
An inventor may obtain several benefits from patenting an invention, in addition
to any personal gratification that results from simply owning a patent. A patent
owner may realize profits from making, using, or selling the invention, or by
74. See generally MPEP, supra note 25, at ch. 1200 (detailing appeal procedures); MPEP, supra note 25,
at § 201.07 (focusing on continuation applications).
75. The exception is continuation-in-part applications, in which new matter is added. The new matter has
the benefit of the date the new matter was added, rather than the priority date of the original application. MPEP,
supra note § 201.08. This may be important in infringement proceedings when the alleged infringement concerns
the new matter, and the alleged date of alleged infringement is after the original filing date but before the effective
filing date of the new matter.
76. MPEP, supra note 25, at § 713.01 (allowing interviews); 37 C.F.R. § 1.133(a) (2000) (specifying that
interviews for original applications are not granted prior to a first Office Action); MPEP, supra note 25, at § 713.02
(same).
77. MPEP, supra note 25, at § 609.
78. MPEP, supra note 25, at § 1303; MPEP, supra note 25, at § 1306.
79. Tod Preston, An Active Eight Years for IP, USPTO TODAY ONLINE, at 4, at http://www.
uspto.gov/ac/ahrpa/opa/ptotoday/ptotoday I 2.pdf (Dec. 2000).
80. 47,521 patents were issued in 1998, 111,984 in 1997, 109,646 in 1996, and 101,419 in 1995. U.S. Patent
Activity, Calendar Years 1790-1999, at http://www.uspto.gov/web/offices/ac/ido/oeip/taf/hcounts.htm (last
modified Nov. 28, 2000). The PTO reports that approximately 66% of applications filed result in issued patents.
PATENT AND TRADEMARK OFFICE, GENERAL INFORMATION CONCERNING PATENTS: EXAMINATION OF APPLICATIONS
AND PROCEEDINGS IN THE PATENT AND TRADEMARK OFFICE, at http://www.uspto.gov/web/offices/pac/doc/general/
exam.html (last visited Jan. 17, 2001).
81. Preston, supra note 79, at 4.
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assigning or licensing rights to make, use or sell the invention.82 The protection that
a patent provides is as close as one can come to idea protection, and the grant of
patent rights is exclusive.83 Competitors may then be forced to design around the
patent if they decide to market competing products. Independent invention and
reverse engineering are not defenses to patent infringement; 84 any unlicenced
practice of the claimed invention constitutes infringement.85
On the other hand, obtaining a patent is also rife with disadvantages. In
exchange for the right to exclude, one must disclose the invention such that one
skilled in that art could practice the invention after reading the patent.86 During the
patent term, the patent serves only as a hurdle to competition, rather than a complete
bar. Once the patent term is over, the invention passes into the public domain such
that anyone may make, use, or sell it.87 A patent may take years to obtain, which cuts
into the patent term and affects the potential profit that the patent owner may
realize. 88 Patents are, by far, the most expensive form of intellectual property
protection.89 They are expensive to obtain and maintain, and even more expensive
to enforce. 9° Accordingly, an inventor should consider whether the ends justify the
means when obtaining a patent.
82. Regarding licensing, see generally Paul L. Hickman, The Patent and Technology License, 496 PLI/PAT
251 (1997).
83. See 35 U.S.C.A. § 154 (a)(1) (West Supp. 2000) ("Every patent shall contain... a grant to the patentee,
his heirs or assigns, the right to exclude others .... ").
84. In other areas of intellectual property law, such as copyright law and trade secret law, independent
invention and reverse engineering are valid defenses to infringement. See Baltimore Orioles, Inc. v. Major League
Baseball Players Ass'n., 805 F.2d 663, 668 n.6 (7th Cir. 1986) ("For a work to be copyrightable, it must be original
and creative, but need not be novel. (Thus, in contrast to patent law, a work that is independently produced by two
separate authors may be copyrighted by both.)"), cert. denied, 480 U.S. 941 (1987); Uniform Trade Secrets Act,
CAL. CIV. CODE § 3426.1 (1984 Addition, West 1997) (remarking that independent invention and reverse
engineering are permissible methods of obtaining a trade secret).
85. See generally 35 U.S.C.A. §§ 271-272 (West 1984 & Supp. 2000) (concerning infringement of patents).
86. Id. § 112.
87. See id. § 154(a)(2) (granting exclusionary rights for a term of twenty years from the filing date of the
application, after which time the patent expires).
88. See id. (mandating that the term of patent protection begin at the filing date, rather than the issue date,
of the application).
89. See supra text accompanying notes 7-10 (comparing government fees for different forms of intellectual
property protection); infra Part III.F (discussing the cost of patent protection with respect to particular patents).
90. At a minimum, an applicant must pay a basic filing fee and the issue fee. 37 C.F.R. § 1. 16(a) (2000); id.
1.18(a) (2000). After the patent issues, maintenance fees are required to maintain the patent in force. Id. § 1.20(e)-(g)
(2000) (regarding maintenance fees due at three and a half, seven and a half, and eleven and a half years after the
patent grant). See infra Part IM.F (exploring cost details for particular patents). Estimates of patent infringement
costs are in the range of 6-7 figures, but patent insurance is available. See Lawrence Lessig, The Problem with
Patents, at http://www.the standard.com/article/display/0,1 151,4296,00.html (Apr. 23, 1999) ("On average it takes
$1.2 million to challenge the validity of a patent .... ").
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III. PATENTS YOU CAN INFRINGE IN YOUR OWN HOME
The right to exclude others from practicing a patent is desirable. Revenue or
royalties from other people involved in the making, selling, or using of a product
can be lucrative, even if for a limited time. A patent, however, is only valuable to
the extent that the holder may enforce it against infringers. Without a practicable
method of enforcement, the patent is economically worthless. Economic viability
of a patent is an important consideration, considering the cost of patent protection. 9'
Some of the following patents beg the question of whether the cost of patent
protection is justified, considering their prospects for enforcement and profitability.
A. U.S. Patent No. 3,418,999
Method of Swallowing a Pill
"The invention relates to overcoming the difficulty experienced by some
persons of gagging or choking while swallowing medicinal pills. '92 The inventor
further notes the problem of the "playful tongue" in traditional pill-swallowing
methods. 93 The claims are drawn to a new method of swallowing a pill, requiring a
pill of a particular density and volume range.94 Davis teaches a "bowed head"
method in which the person's head is tilted forward, such that the pill floats, is
nearer the throat, and is more easily swallowed. 95 This method is consistent with
"the procedure used by animals, as well as by primitive man, in drinking from
ponds, streams, etc.",96 Pills may be treated to ensure flotation by adjusting their
densities. 97
The original application was filed on February 12, 196498 with twelve claims,
nine directed to a pill and the remaining three directed to a method for swallowing
a pill.99 The PTO issued an Office Action in May 1967, rejecting all claims.'0° The
nine claims to the pill itself were rejected for obviousness 10 1 or as reading on prior
art. 102 The method claims were rejected as "obvious or inherent" in taking a pill with
91. See infra Part nI.F (discussing the costs of obtaining a patent).
92. U.S. Patent No. 3,418,999, col. 1, 11. 10-13 (issued Dec. 31, 1968).
93. Id., col. 1, I1. 45-47.
94. Id., col. 6, II. 25-57.
95. Id.,col. 3,11.4-11;id.,Fig. 2.
96. id., col. 3,11. 13-15.
97. Id., col. 4, 1. 10-col. 5, 1. 47.
98. File Wrapper, U.S. Patent No. 3,418,999, Form PO-436a.
99. Id., Patent as Filed, at 12-13.
100. Id., Office Action, May 1967, at 4.
101. Id. at 1-2 (citing U.S. Patent No. 2,797,201 (issued June 25, 1957) (buoyant plastics), U.S. Patent
No. 2,841,528 (issued July 1, 1958) (medicinals), U.S. Patent No. 3,012,893 (issued Dec. 12, 1961) (gasified fused
sugar confection)).
102. Id. at 2 (referring to puffed cereals and "slack-filled gelatin capsule[s] containing powdered medicine").
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water from a drinking fountain.'0 3 Additionally, these claims were rejected under
section 101 "as being frivolous and lacking statutory evidence establishing the
applicant's unsubstantiated allegations and inventive objectives of eliminating the
discomforts of gagging and/or a pill stuck in the esophagus,"' 4 with a report of the
assistant examiner's attempts to practice the method. 0 5 In response, the applicant
filed an amendment canceling the nine claims directed to the pill10 6and requested
reconsideration of the rejection of the method claims, detailing results of trials using
the method. 0 7 A supplemental amendment was subsequently filed to amend the
method claims to further specify the relevant density of the pills in conformity with
a telephone interview with the examiner. 108 A Notice of Allowance was mailed on
August 29, 1968,'09 and the patent issued on December 31, 1968."0
This patent offers virtually no prospects for enforcement. Possible prospects for
licensing this patent might include health care professionals or perhaps schools to
use as an alternate method for people who have trouble swallowing pills. Perhaps
the inventor could have licensed the method for use in a motion picture in which a
character chooses to swallow pills in this manner on screen, but it is unlikely that a
filmmaker would pay to use this method in a motion picture when there are a
multitude of pill-swallowing methods in the public domain. Realistically, the
practice of this invention is a relatively private issue; it is rather difficult to know
how one takes pills in the privacy of one's own home (or one's own mouth!).
Deterring infringement of this particular patent is practically impossible, so there
would be little point in paying the inventor for a license. Thus, this patent has very
little economic viability for the inventor.
B. U.S. Patent No. 4,887,543
Unforgettable Umbrella Method
"Most all persons have forgotten and ultimately lost a number of umbrellas
during their lifetime.""'. The '543 patent 12 addresses this problem by providing "a
method to aid the memory in remembering to retrieve an umbrella upon leaving a
building from a location where the umbrella was placed upon entrance to the
103. Id. at 2-3.
104. Id. at 3.
105. Id.
106. Id., Amendment, Nov. 27, 1967, at 1.
107. Id. at 3-7.
108. Id., Supplemental Amendment, Jan. 25, 1968, at 1-3.
109. Id., Notice of Allowance, Aug. 29, 1968.
110. U.S. Patent No. 3,418,999 (issued Dec. 31, 1968).
111. U.S. Patent No. 4,887,543, col. 1, 11. 7-8 (issued Dec. 19, 1989).
112. Because there are over six million patents, the convention is to refer to patents by the last three digits
once the entire reference has been provided.
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building .... ,,1 13 The claims provide for an "eye means"'14 on the umbrella handle,
which receives an identification "member."" 5 This member may also attach to a key
ring.1 6 When the umbrella is left at a location, the member is detached from the
umbrella and attached to a key ring.'"7 Upon looking at one's keys, one may easily
determine that the umbrella was left behind and backtrack to retrieve it.118
Dependent claims regarding the design on the identification clip are also present in
the patent. 119
The prosecution history for the '543 patent is rather unrevealing. The
application, as filed on March 9, 1989, contained fifteen claims and cited six patents
as prior art. 20 The examiner conducted a telephone interview with the applicant's
lawyer on July 26, 1989, and he mailed a Notice of Allowability on July 27th. 12' As
a result of the interview, two claims were combined to avoid duplicating a different
claim, and the claim whose contents were incorporated was deleted. 122 The Notice
also contained several patents that the examiner cited as prior art, some involving
umbrellas 123 and others involving identification and retrieval systems.' 24 This patent
issued on December 19, 1989, with a total prosecution time of approximately nine
months. 1
25
The broadest claim of the patent is directed to a method for remembering to
retrieve an umbrella-requiring an umbrella with "eye means," a clip-bearing
identification member and a key ring. 126 Some of the dependent claims are directed
to the elements of the method: the umbrella with eye means, 127 the identification
113. U.S. Patent No. 4,887,543, cot. 3,11.46-49 (issued Dec. 19, 1989).
114. Id., cot. 3,1. 50.
115. Id., cot. 3, 11. 52-57.
116. Id., cot. 3, 11. 65-67.
117. Id., cot. 3, 11. 58-67.
118. Id., cot. 4,11. 1-3.
119. Id., cot. 4, 11. 19-20 (specifying a "flower design"); id., cot. 4, 11. 62-63 (same); id. cot. 6, 11. 15-16
(same).
120. File Wrapper, U.S. Patent No. 4,887,543, Patent as Filed, Mar. 9, 1989, at 9-12; id., Form PTO- 1449,
List of Prior Art Cited by Applicant, Mar. 9, 1989 (citing U.S. Patent No. 2,128,634 (issued Aug. 30, 1938)
(umbrella); U.S. Patent No. 2,759,486 (issued Aug. 21, 1956) (attachment for beach umbrella); U.S. Patent
No. 2,838,058 (issued June 10, 1958) (drip-retaining attachment for umbrella); U.S. Patent No. 4,542,757 (issued
Sept. 24, 1985) (umbrella with advertising flag); U.S. Patent No. 4,257,342 (issued Mar. 24, 1981) (position
indicator for fireplace damper); U.S. Patent No. 4,236,479 (issued Dec. 2, 1980) (device for reminding driver to turn
off auto headlights)).
121. Id., Examiner Interview Summary Record, July 26, 1989; id., Notice of Allowability, July 27, 1989.
122. Id., Examiner Interview Summary Record, July 26, 1989; id., Notice of Allowability, July 27, 1989.
123. See id., Notice of Allowability, July 27, 1989, at 2-3 (citing U.S. Design Patent No. D287,665 (umbrella
with integral eye means); U.S. Patent No. 2,493,705 (same); U.S. Patent No. 4,586,524 (combination umbrella and
garment hanger); Swiss Patent 584,016 (indicia sewn on umbrella cover); British Patent 481,581 (indicia that may
be attached to the handle of umbrella)).
124. See id., Notice of Allowability, July 27, 1989, at 2-3 (citing U.S. Patent No. 1,369,846 (umbrellas); U.S.
Patent No. 4,521,981 (key ring); U.S. Patent No. 4,592,157 (vehicles); French patent 1,497,493 (key ring)).
125. U.S. Patent No. 4,887,543 (issued Dec. 19, 1989).
126. Id., cot. 3, 1. 45-col. 4, 1. 3. See also id., cot. 4., 11. 4-8.
127. Id., cot. 4,11. 9-11.
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member, 128 and so on. An eye means for the umbrella could include, for example,
the straps often attached to umbrella handles. Any clip capable of being removably
attached to either a key ring or the umbrella strap would function as the
identification means. A person who moves the clip from the key ring to the umbrella
strap upon leaving the umbrella somewhere would then infringe the patent.
Infringement of this patent would be simple to effect and difficult to detect.
Prospects for licensing this patent are greater than those for the pill-swallowing
patent of Part III.A. One could imagine manufacturing umbrella handles with
integral eye means that the claims would read on. 129 Since the use of such a product
is more public than, for example, swallowing a pill, the existence of this type of
license is easier to imagine. Apparently, the inventor found little success with her
patent, however, for the patent expired after four years due to failure to pay the first
maintenance fee. 1
30
C. U.S. Patent No. 5,443,036
Method of Exercising a Cat
The inventors of a cat-exercising method decry the lack of methods for inducing
cats to engage in aerobic exercise.' 13 They state that cats are "fascinated by light"'
132
and maintain that cats will chase after "lighted image[s],"'' 33 but note that "[t]he
disruption of having to darken a room to stage a cat workout and the uncertainty of
collecting a convenient sunbeam in a lens or mirror render these approaches to
establishing a regular life-enhancing cat exercise routine inconvenient at best."'
134
Accordingly, the claims are directed to a cat-exercising method that entails using,
for example, a laser pointer's beam to produce a "pattern [of light] of visual interest
to a cat"'135 and moving that pattern of light "to induce said cat to run and chase [the
pattern].' 36 The patent has three dependent claims, which limit the independent
claim with regard to the size of the pattern, 137 the visibility of the beam,'38 and the
speed at which the beam is moved about.1
39
128. Id., col. 4, 11. 12-14; id. col. 4, 11. 55-57.
129. If a claim "reads on" a reference, that claim includes the reference within its scope. See, e.g., MPEP,
supra note 25, at § 806.04(d) ("In an application presenting three species .... a generic claim should read on each
of these views ...."); MPEP, supra note 25, at § 2173.04 ("If the claim is too broad because it reads on the prior
art, a rejection under either 35 U.S.C. 102 or 103 would be appropriate.").
130. See supra note 90 (relating to the requirement of maintenance fees); infra Part III.F (discussing PTO fees,
including maintenance fees, for the patents in this section).
131. U.S. Patent No. 5,443,036, col. 1, I1. 11-15 (issued Aug. 22, 1995).
132. Id., col. 1, 1. 16.
133. id., col. 1, 1. 23.
134. Id., col. 1, II. 24-28.
135. Id., col. 2, 11. 62-66.
136. Id., col. 2, 1. 68-col. 3, 1. 2.
137. Id., col. 3, I1. 3-4.
138. Id., col. 3, 1. 5-col. 4, 1. 2.
139. Id., col. 4,11. 3-6.
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The application was filed on November 2, 1993; the applicants subsequently
cited several prior art patents directed to laser pointers, "illuminators," and "light
toys" in an Information Disclosure Statement (IDS).1 40 The original filing contained
five claims:
1. A method of exercising a cat comprising the steps of:
(a) directing a coherent beam of light produced by a hand-held laser
apparatus to produce a bright pattern of light at the intersection of
the beam and an opaque surface, said pattern being of visual
interest to a cat; and
(b) selectively redirecting said beam to induce said cat to chase said
beam and pattern of light around an exercise area.
2. The method of claim 1 wherein said hand-held laser apparatus produces
a beam of coherent red light.
3. The method of claim 1 wherein said bright pattern of light is small in
area relative to a paw of the cat.
4. The method of claim 1 wherein said beam remains invisible between
said laser and said opaque surface until impinging on said opaque
surface.
5. The method of claim 1 wherein step (b) includes sweeping said beam
at an angular speed to cause said pattern to move along said opaque
surface at a speed in the range of five to twenty-five feet per second.
14 1
The examiner mailed a first Office Action on August 22, 1994, rejecting all five
claims for obviousness. 142 In rejecting the claims, the examiner cited a publication
by Carayan et al. involving the use of light for stimulation of reflexive movements
in cats.143 The reference involved a beam of light that was directed using an
electronic system; the examiner stated that manually directing the beam would be
obvious to one skilled in the art.144 Additionally, the examiner rejected claim 2,
finding the color of the light irrelevant to the method. 45 The examiner cited two
additional prior art references in this Office Action. 146 In response, the applicants
140. File Wrapper, U.S. Patent No. 5,443,036, Information Disclosure Statement, Jan. 10, 1994 (citing U.S.
Patent No. 4,208,701 (issued June 17, 1980) (luminous toy); U.S. Patent No. 4,231,077 (issued Oct. 28, 1980) (light
toy); U.S. Patent No. 4,757,515 (issued July 12, 1988) (laser tube casing); U.S. Patent No. 4,761,715 (issued Aug.
2, 1988) (laser pointer); U.S. Patent No. 4,926,438 (issued May 15, 1990) (laser pointer); U.S. Patent No. 4,985,029
(issued Jan. 15, 1991) (laser apparatus for medical treatment); U.S. Patent No. 5,056,097 (issued Oct. 8, 1991)
(target illuminators); U.S. Patent No. 5,194,007 (issued Mar. 16, 1993) (semiconductor laser weapon trainer)).
141. Id., Patent as Filed, Nov. 2, 1993, at 7.
142. Id., Office Action, Aug. 22, 1994, at 2.
143. Id. at 2-3; id., Form PTO-892, Notice of References Cited, Aug. 16, 1994.
144. Id., Office Action, Aug. 22, 1994, at 2.
145. Id. at 2-3.
146. Id., Form PTO-892, Notice of References Cited, Aug. 16, 1994 (citing U.S. Patent No. 3,877,171 (issued
Apr. 15, 1975) and a publication by Levesque, et al., containing a method similar to Carayan, et al.).
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attempted to distinguish the examiner's publication references by amending claim 1
to recite "under normal lighting conditions.' ' 47 The applicants noted the use of an
"arcane apparatus" which was "analogous to nothing in the home of a typical cat
owner."' 148 They claimed that the publications actually taught away 149 from the
invention because the cats in the experiment were restrained, 5° while the purpose
of the invention is to exercise the cat by enticing it to move about.'5 ' Claim 2 was
cancelled.'
A second Office Action was mailed on January 10, 1995, rejecting the four
remaining claims using the Carayan et al. reference. 153 The examiner again stated
that manipulating the laser manually would be obvious to one skilled in the art.
15 4
Carayan et al., according to the examiner, makes no reference to lighting conditions
and "is deemed to take place 'under normal lighting conditions"'; thus, the applicant
gained no advantage from the amendment to claim 1.155 This Office Action was
made final, requiring either an amendment to place the application in a position to
issue, the filing of a continuation application to continue prosecution, or the filing
of a notice of appeal.
156
A telephone interview between the examiner and the practitioner was conducted
on March 8, 1995.157 The examiner viewed a videotape of the invention and the
Carayan et al. reference, in addition to a patent issued to Sloop, 158 was discussed
with respect to claim 1. According to the record, the examiner required and
proposed an amendment to claim 1 to overcome prior art. 59 The applicants filed an
amendment on March 10, 1995, incorporating the examiner's changes. 6' In
addition, further remarks were included to distinguish the invention from that
147. Id., Amendment, Nov. 1, 1994, at 1.
148. Id. at 3.
149. Id. (stating that Carayan, et al. "solves a non-analogous problem with non-analogous apparatus").
"Teaching away" is a part of the obviousness determination. See United States v. Adams, 383 U.S. 39, 714-15
(1966) ("[Kinown disadvantages in old devices which would naturally discourage the search for new inventions
may be taken into account in determining obviousness."); In re Rosenberger, 386 F.2d 1015, 1018 (C.C.P.A. 1967)
("The teaching [of the prior art] therefore discourages research in the very field where appellants made their
invention.... They have invented a method... in the face of art which strongly suggests that such a method would
produce unacceptable results. This is the very antithesis of obviousness.").
150. File Wrapper, U.S. Patent No. 5,443,036, Amendment, Nov. 1, 1994, at 3.
151. See U.S. Patent No. 5,443,036, col. 2, 11. 12-17 (issued Aug. 22, 1995) (regarding the purpose of the
invention).
152. File Wrapper, U.S. Patent No. 5,443,036, Amendment, Nov. 1, 1994, at 1.
153. Id., Office Action, Jan. 10, 1995, at 2-3.
154. Id. at2.
155. Id. at 2-3.
156. MPEP, supra note 25, at § 714.13.
157. File Wrapper, U.S. Patent No. 5,443,036, Examiner Interview Summary Record, Mar. 8, 1995.
158. Id., Office Action, Form PTO-892, Notice of References Cited, Aug. 16, 1994 (citing U.S. Patent
No. 3,877,171 (issued Apr. 15, 1975)).
159. Id., Examiner Interview Summary Record, Proposed Amendment, Mar. 8, 1995.
160. Id., Amendment, Mar. 10, 1995, at 1-3.
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disclosed in Sloop. 16 ' Great emphasis was placed on the description of the laser
beam as having "focused coherence."'' 62 Sloop is distinguished by characterizing its
beam of light as "eccentrically rotating" and "better suited to visual entertainment
than directed exercise."' 163 The patent ultimately issued on August 22, 199 5 .t64
Licensing prospects for this patent are about as bleak as those for the pill-
swallowing method, for one typically plays with cats in the privacy of one's home.
A filmmaker might wish to pay to use this type of method in a movie, or develop
instructional videos on how to exercise a cat. According to the file wrapper, an
action was filed on this patent in March of 1997, but further details were not
available. 65 This patent continues to be in force; evidently, the inventor found it
worthwhile to pay the first maintenance fee.
D. U.S. Patent No. 5,616,089
Method of Putting
"Many golfers would like to improve their putting." 66 Accordingly, this patent
teaches a method to improve control when putting a golf ball by using the golfer's
dominant hand to lead the stroke while the non-dominant hand acts as a stabilizer. 167
All thirteen claims are drawn to the position of the hands in the grip used by the
golfer.1
68
This patent, like that of the umbrella method, was granted rather speedily, taking
about a year from filing to issue. 169 The applicant filed an application on March 29,
1996170 and an IDS on May 30, 1996;' 7 1 the examiner mailed a Notice of
Allowability on September 5, 1996.172 The applicant cited prior art references
referring to grips used by two professional golfers. 173 The examiner cited five
patents as prior art references with the Notice of Allowability 174 and cited the lack
161. Id. at 3.
162. id.
163. Id.
164. U.S. Patent No. 5,443,036 (issued Aug. 22, 1995).
165. Id., Report on the Filing or Determination of Action Regarding a Patent or Trademark.
166. U.S. Patent No. 5,616,089, col. I, 1.9 (issued Apr. 1, 1997).
167. Id., col. 1, 11. 28-32; id. Figs. 1-3.
168. Id., col. 4, 1. 1-col. 6, 1. 13.
169. File Wrapper, U.S. Patent No. 5,616,089, Cover Sheet.
170. Id., Patent as Filed, Mar. 29, 1996.
171. Id., Information Disclosure Statement, May 30, 1996.
172. Id., Notice of Allowability, Sept. 5, 1996.
173. Id., Information Disclosure Statement, May 30, 1996, at 1.
174. Id., Form PTO-892, Notice of References Cited (citing U.S. Patent No. 3,263,998 (issued Aug. 2, 1966)
(method of using a golf club), U.S. Patent No. 3,486,755 (issued Dec. 30, 1969) (putter with head-aligning means),
U.S. Patent No. 4,067,573 (issued Jan. 10, 1978) (putter grip), U.S. Patent No. 4,272,077 (issued June 9, 1981)
(putter grip), U.S. Patent No. 4,605,228 (issued Aug. 12, 1986) (method of putting)).
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of prior art as a reason for allowance in his comments. 75 The patent issued on April
1, 1997.76
When regarding this patent, directed to a particular hand grip on a golf club, it
seems to lack viability. This patent, however, is unlike the cat-exercising patent
discussed in Part III.C in that golf instructional videos are a lucrative business.
While the local, small-time golfer may be able to infringe this patent without much
fear of a lawsuit, no professional golfer could do so in this age of televised sports.
If the inventor were an avid follower of golf, he might one day spot a professional
golfer infringing his patented method on television and subsequently bring suit.
Identifying the right potential defendants in a patent infringement suit is an
important strategic consideration, and this patent is ideally suited to such a
strategy. 177
E. U.S. Patent No. 5,638,831
Method of Preventing Repetitive Stress Injuries During Computer
Keyboard Usage
"Typing at a computer keyboard may not be a sport, but with [repetitive stress
injuries] becoming so prevalent, it is clear that it must be seen as an athletic
activity . . . .Typing may be microathletic, but it is athletic nonetheless."'
178
Solutions to the problems of repetitive stress injuries (RSIs) have been ineffective
and impractical, providing the impetus for this inventor to develop a method for
preventing RSIs.179 The claims of this patent are directed to hand-positioning
methods for both keyboards and computer mice. 8°
The application, filed November 8, 1994, contained fourteen claims and cited
no prior art.' 81 Subsequently, an IDS was filed, listing several references directed to
methods of playing a piano. 82 An Office Action dated March 6, 1996, objected to
the specification as not meeting the written description requirement, 183 objected to
all fourteen claims for failing to meet the written description requirement,' 84 and
rejected all fourteen claims for indefiniteness. 185 The examiner also cited four prior
175. Id., Notice of Allowability, Sept. 5, 1996, at 2.
176. U.S. Patent No. 5,616,089 (issued Apr. 1, 1997).
177. See generally Jeffrey A. Smith, Comment, It's Your Move-No It's Not! The Application of Patent Law
to Sports Moves, 70 U. COLO. L. REV. 1051 (1999).
178. U.S. Patent No. 5,638,831, col. 1, 11.39-43 (issued Jun. 17, 1997).
179. Id., col. 1, 1. 52-col. 2,1. 46.
180. Cf id., col. 12, I1. 48-55 (keyboard); id., col. 12, 11. 56-63 (computer mouse).
181. See generally File Wrapper, U.S. Patent No. 5,638,831, Patent as Filed, Nov. 8, 1994.
182. Id., Information Disclosure Statement, Form PTO- 1449, List of References Cited by Applicant, Feb. 8,
1995.
183. Id., Office Action, Mar. 6, 1996, at 2.
184. Id.
185. Id.
2001 / Eat Your Vegetables and Be Sued for Patent Infringement
art references disclosing keyboards and support braces, 86 though none of these
references were used to reject any of the claims in the application.'87
The objections and the rejections rested on the examiner's statement that the
reference to a "fluid line" was unclear.' 88 The amendment in response to this Office
Action replaced "fluid line" with "natural line" to indicate that the arm position
referred to in the method was the natural line of the arm when it rests at one's
side. 89 The applicant also chose to further distinguish the examiner's prior art
references.' 9° A Notice of Allowability was mailed on June 25, 1996, allowing all
fourteen claims.' 9' An amendment was filed after this notice, correcting various
typographical errors and assuring conformity between the specification and the
drawings. 192 All other communications regarding the application before issuance of
the patent related to the submission of formal drawings, rather than any substantive
patentability issues. 193 The patent issued on June 17, 1997.' 9 4
The economic viability of this patent, like that of the putting method discussed
in Part III.D, lies in the proliferation of instructional videos. While many people
may practice such a method in private and are therefore undetectable vis-d-vis patent
infringement suits, the computer industry has made ergonomics a profitable
business. One may imagine instructional videos demonstrating the patented method,
or even training courses for the method as a separate avenue of profitability. '9
186. Id., Office Action, Form PTO-892, Notice of References Cited, Mar. 6, 1996 (citing U.S. Patent
No. 5,086,762 (issued Feb. 11, 1992) (typing brace), U.S. Patent No. 5,336,001 (issued Aug. 9, 1994) (keyboard),
U.S. Patent No. 5,369,805 (issued Dec. 6, 1994) (arm support), U.S. Patent No. 5,492,291 (issued Feb. 20, 1996)(keyboard)).
187. Id., Office Action, Mar. 6, 1996.
188. Id. at 2.
189. Id., Amendment, Apr. 3, 1996, at 8-9.
190. Id. at 9-11.
191. Id., Notice of Allowability, June 25, 1996.
192. Id., Amendment Under 37 C.F.R. § 1.312(a), Aug. 16, 1996, at 3. See 37 C.F.R. § 1.312(a) (2000).
193. File Wrapper, U.S. Patent No. 5,638,831, Interview Summary, Oct. 8, 1996; id., Request Under 37
C.F.R. § 1.312(b) for Approval of Drawing Changes, Oct. 7, 1996; id., Submission of Formal Drawings, Sept. 25,
1996.
194. U.S. Patent No. 5,638,831 (issued June 17, 1997).
195. Ergonome, Inc., the assignee of this patent, published a book and computer software demonstrating the
patented method. In 1997, Compaq Computer Corporation filed suit against Ergonome, seeking a declaration of
noninfringement for the guide that Compaq distributes with its computers. Memorandum Opinion and Order,
Compaq Computer Corp. v. Ergonome, Inc. et al., Civil Action No. H-97-1026, at 3 (S.D. Tex. 2001). In 1998,
Ergonome filed suit against Compaq Computer Corporation in the Southern District of New York, seeking $10.2
billion in damages for copyright infringement and fraud. Rebecca Sykes, Compaq Named in $USIO Billion Lawsuit,
athttp://www.idg.net.nz/webhome.nsf/ArchiveDate/68CBD9AAA07BFBA6CC25684CE F! OpenDocument(June 15, 1998); Too Close for Ergonomic Comfort, HOUSTON Bus. J., June 19, 1998, available at http://houston.
bcentral.com/houston/stories/1998/06/22/tidbits.html (June 22, 1998). The latter action was transferred to the
Southern District of Texas where it was consolidated with the first. Memorandum Opinion and Order, supra, at 3.See also Ergonome Incorporated's Second Amended Complaint and Counterclaim, Civil Action No. H-97-1026(Consolidated with CA H-98-3159) (S.D. Tex. 2001), at http://www.justiceseekers.com/files/NLP P00000/032.PDF.
See generally http://www.justiceseekers.com (last modified Apr. 18, 2001) (providing information about the
litigation).
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E The Cost of an "Unenforceable" Patent
The following table.reflects the costs involved in obtaining and maintaining
these patents. 196 Fees for the patent practitioner's services in handling the application
and maintenance of the patent in force, in addition to other PTO costs incurred in
prosecuting the application to issuance, increase the total cost. In all likelihood, the
present benefit to most of these inventors in obtaining these patents does not justify
the costs of prosecution and maintenance.
Patent Filing Issue Ist 2nd 3rd Total
Fee Fee Maint. Maint. Maint. Fees
Davis $30 $134 N/A N/A N/A $164
(12/31/68) , "
Rockhill $170 $310 $465 $1,025 $1,455 $3,425
(12/19/,89) (6/93) (6/97) (6/01)
Amiss, et al. $355 $605 $470 $950 $1,455 $3,935
(8/22/95) (2/99) (10/04) (10/08)
Miller $414 $625 $470 $950 $1,455 $4,014
(4/01/97) (10/00) (10/04) (10/08)
Brown $365 $625 $470 $950 $1,455 $3,965
(6/17/97) (12/00) (12/04) (12/08)
IV. CASE IN POINT: BROCCOLI SPROUTS
Perhaps the question of whether a patent is economically viable is more
appropriately answered by considering against whom it may be enforced. A patent
owner may be willing to forgo enforcement of the patent against some, such as the
undetectable home infringer, but may pursue a more accessible infringer. The
196. With respect to the numbers in the table, the amounts actually paid for filing and issue fees are available
on the cover sheet of the file wrapper for the relevant patent. Regarding maintenance fees, any fees due after
October 1, 2000 used fees in the 2000 edition of 37 C.F.R. as an approximation. 37 C.F.R. § 1.16(a) (2000) (basic
filing fees); id. § 1.18(a) (2000) (issue fees); id. § 1.20(e)-(g) (2000) (maintenance fees). Older fee schedules are
found in 63 Fed. Reg. 67,578, 67,580 (Dec. 8, 1998, superseding final rule published on July 24, 1998 and corrected
on Sept. 3, 1998) (effective Nov. 10, 1998) (maintenance fees in effect on Feb. 22, 1999); 61 Fed. Reg. 39,585,
39,588 (July 30, 1996) (effective Oct. 1, 1996) (maintenance fees in effect on June 19, 1997); 57 Fed. Reg. 38,190,
38,195 (Aug. 21, 1992) (effective Oct. 1, 1992) (maintenance fees in effect on June 19, 1993). Maintenance fees
were not necessary for applications filed before December 12, 1980. MPEP, supra note 25, at § 2501. Each of these
inventors filed as a small entity, entitling them to pay one-half of the regular fees. See 37 C.F.R. § 1.9(f) (2000)
(defining "small entity" and establishing when small entity status is relevant); id. § 1.27 (2000) (regarding
statements verifying small entity status).
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following patents emanated from research at Johns Hopkins University. Researchers
discovered that certain types of vegetables, including broccoli, contained
compounds, synthetic analogues of which were found to "block chemical
carcinogenesis in animals." 197 Four patents were granted relating to this research.198
The claims in these patents seem to be easily infringed, similar to the patents
considered in Part III. These patent owners, however, have found a target for
infringement suits.99
A. The Four Patents
Green and yellow vegetables have been linked to lower incidence of cancer.2"
Induction of phase II enzymes was thought to be connected to these chemoprotective
properties. 20' Broccoli, in particular, was found to have significant phase II enzyme-
inducing characteristics. 2 2 In 1992, researchers at Johns Hopkins University
published an article reporting the isolation of a particular compound from broccoli
responsible for inducing phase II enzyme activity. 20 3 Spectroscopic analysis revealed
that the compound in question was likely to be sulforaphane, an isothiocyanate. 204
Previous studies revealed that isothiocyanates, in particular, produced
anticarcinogenic effects, suspected to be linked to their phase II enzyme-inducing
205activities. In 1997, these researchers published a paper reporting that broccoli
sprouts contained very high levels of isothiocyanates, including sulforaphane.20 6
They concluded that young (3-day) sprouts contain ten to one-hundred times as
much phase II enzyme inducer activity as mature broccoli vegetables.2 7
Each of the four patents issuing from this research contains claims directed to
germinating and harvesting sprouts of certain plants in the Brassica family and to
administering those sprouts to a mammal.2 8
197. U.S. Patent No. 5,968,505, col. 2, 11. 4-6 (issued Oct. 19, 1999). See generally Jed W. Fahey et al.,
Broccoli Sprouts: An Exceptionally Rich Source of Inducers of Enzymes that Protect Against Chemical
Carcinogenesis, 94 PROC. NAT'L ACAD. SCi. 10,367 (1997); Marion Nestle, Broccoli Sprouts as Inducers of
Carcinogen-Detoxifying Enzyme Systems: Clinical, Dietary and Policy Implications, 94 PROC. NAT'L ACAD. SCI.
11,149 (1997); HansJ. Prochaskaet al., Rapid Detection of Inducers of Enzymes that Protect Against Carcinogens,
89 PROC. NAT'L ACAD. Sci. 2,394 (1992); Yuesheng Zhang et al., A Major Inducer ofAnticarcinogenic Protective
Enzymes from Broccoli: Isolation and Elucidation of Structure, 89 PROC. NAT'L ACAD. Sci. 2,399 (1992).
198. See infra Part IV.A. 1-4 (exploring the four patents).
199. See infra Part IV.B (regarding lawsuits filed by Johns Hopkins and the patent assignees).
200. Zhang et al., supra note 197, at 2,399; U.S. Patent No. 5,411,986, col. 2,11. 14-26 (issued May 2, 1995).
201. Zhang et al., supra note 197, at 2,399.
202. Id.
203. Id.
204. Id. at 2,400-01.
205. Id. at 2,402-03.
206. Fahey et al., supra note 197, at 10,367.
207. Id. at 10,372.
208. See infra Part W.A. 1-4 (quoting relevant language from each of the four patents).
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1. U.S. Patent No. 5,411,986 (Cho et al.)
Chemoprotective Isothiocyanates
U.S. Patent No. 5,411,986 is the first of the four patents granted to the
researchers from Johns Hopkins concerning their discovery of the chemoprotective
effects of glucosinates. It contains claims directed to the compounds discovered and
to "administering to a mammal a chemoprotective composition ... in an amount
effective in producing a mammary tumor or hepatoma formation suppressing
effect."209
The patent application was filed on March 12, 1993, with twenty-five claims.
210
Claims 1 through 23 were directed to chemical compounds, claim 24 was directed
to "a method for protecting against cancer induction," and claim 25 was directed to
"a food product.., supplemented with" the compound of the instant invention.21'
Two IDSs were filed prior to issuance of the first Office Action on October 20,
1993.2 The examiner rejected claims 1 though 24 and withdrew claim 25 from
consideration, the applicant earlier having elected to prosecute the invention of
claims 1 through 24.213 The specification and claims were rejected for failure to
provide an enabling disclosure and for indefiniteness.21 4 The claims were also
rejected for lack of utility: "Applicant discloses that the compounds of the invention
are useful as anti-tumor (cancer) agents. However, in view of the contemporary
knowledge in the art, this assertion is incredible on its face. One skilled in the art
would deem this assertion unlikely to be correct. ''215 To overcome this rejection, the
examiner required proof "which would be convincing to those of ordinary skill in
the art."2 16 In response, the applicants began by distinguishing claims which were
not indefinite under the examiner's rejection, then traversing the indefiniteness
rejection.2  Regarding the alleged lack of utility, the applicants pointed to
recitations in the specification and submitted a declaration as the requested proof of
chemoprotective properties.218 A second Office Action, issued on April 7, 1994,
again rejected claims one through twenty-four.219 The examiner persisted in his
rejection for indefiniteness1 22 and found the declaration inadequate in providing an
enabling disclosure for the claims, finding it to be "not commensurate in scope with
209. U.S. Patent No. 5,411,986, col. 22,11. 31-48 (issued May 2, 1995).
210. File Wrapper, U.S. Patent No. 5,411,986, Cover Sheet.
211. Id., Patent as Filed, at 38-41.
212. Id., Information Disclosure Statement, May 12, 1993; id., Supplemental Information Disclosure
Statement, July 16, 1993.
213. Id., Office Action, Oct. 20, 1993, at 1-2.
214. Id. at 3-4.
215. Id. at 4.
216. Id. at 4-5.
217. Id., Amendment, Jan. 21, 1994, at 2-4.
218. Id. at 5-6; id., Declaration Under Rule 132, Jan. 20, 1994.
219. Id., Office Action, Apr. 7, 1994, at 1.
220. Id. at 2-3.
2001 /Eat Your Vegetables and Be Sued for Patent Infringement
the breadth of protection sought., 22' He also took exception to the "'prevention' of
cancer" claim and to the use of only one kind of cancer cell in the submitted test
data.222 This Office Action was made final.223
The applicants submitted an amendment after the final rejection, attacking the
examiner's characterization of the claims as indefinite.224 Additionally, they asserted
that the examiner improperly characterized a term as indefinite, submitting a
reference to demonstrate the well-known meaning of the term "in the art of
chemistry. 2 25 The applicants then addressed the lack of an enabling disclosure,
which related to the asserted lack of utility, claiming that "an assertion of
chemopreventive activity is not incredible on its face., 226 Finally, the applicants
addressed the dismissal of the submitted declaration and argued that none of the
reasons given by the examiner should prevent the issuance of a patent. 227 In
response, the examiner issued an Advisory Action, indicating that the rejections
228were not overcome. An interview with the examiner took place on September 20,
1994; no agreement was reached about allowance. 229 The examiner agreed to review
a proposed draft amendment before it was filed.230 The amendment deleted
references to chemoprotective properties in the claims, deleted several claims, and
included text to overcome the rejections based on lack of specificity.231' The
applicant filed a Notice of Appeal on October 7,1994.232 The examiner subsequently
issued a Notice of Allowability, allowing all of the claims then at issue except
one. 3 The patent issued May 2, 1995.34
After issue, the applicants requested a Certificate of Correction to print a
particular reference on the patent. 35 The PTO denied this request, stating that the
applicants cited the reference, but that the citation itself did not conform to the
Manual of Patent Examining Procedure (MPEP) 6 Because of this deficiency, the
examiner did not consider the reference, and it was thus ineligible for citation on the
221. Id. at 3.
222. Id. at 3.
223. Id. at 1.
224. Id., Amendment After Final Rejection, Aug. 8, 1994, at 2-4.
225. Id. at 4 (referring to an organic chemistry textbook).
226. Id. at 5-6.
227. Id. at 6-8.
228. Id., Advisory Action, Aug. 31, 1994.
229. Id., Examiner Interview Summary Record, Sept. 29, 1994.
230. Id.
231. Id., Amendment B After Final Rejection, Oct. 5, 1994, at 1-5.
232. Id., Notice of Appeal, Oct. 5, 1994.
233. Id., Notice of Allowability, Oct. 17, 1994.
234. U.S. Patent No. 5,411,986 (issued May 2, 1995).
235. File Wrapper, U.S. Patent No. 5,411,986, Request for Certificate of Correction, May 24, 1995, at 1.
236. Id., Letter from Mary H. Allen, June 14, 1995.
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face of the patent.237 Subsequently, the applicants filed for reissue of this patent in
1997.238
2. U.S. Patent No. 5,725,895 (Fahey et al.)
Method of Preparing a Food Product from Cruciferous Seeds
U.S. Patent No. 5,725,895 is the first of three patents originating from the same
application. Claim 1 of this patent is directed to germinating particular types of
cruciferous seeds and harvesting them "prior to the 2-leaf stage, to form a food
product comprising a plurality of sprouts. '239
The application for the '895 patent was filed on September 15, 1995.240 As filed,
the application contained forty-seven claims, which included thirteen independent
claims.24' The examiner issued a restriction requirement, requiring the applicants to
choose one of eight sets of claims to prosecute in that particular application.242 The
applicants chose to prosecute the sixteen claims in Group III, "drawn to a method
of preparing a food product rich in glucosinates, ' '243 and reserved the right to file
divisional applications on the non-elected claims.2" On December 24, 1996, the
examiner issued an Office Action rejecting all of the elected claims for obviousness,
citing a Japanese patent (Kenjirou), three publications (Beecher and two by Zhang
et al.), and one U.S. Patent (Cho et al., addressed in Part IV.A. 1).245 According to
the examiner, the references disclose broccoli sprouts and "the cancer preventive
properties of Brassica," such that "[a]pplicant's claims are drawn to a combination
of known components which produces expected results. ,,246
The applicants and their patent attorney conducted an interview with the
examiner on March 11, 1997.247 The applicants presented information regarding the
chemistry involved in the application and particularly addressed the applicability of
the Kenjirou reference to the application, concluding that the translation was
improper and that the elected claims were allowable.248 In an amendment filed on
March 17, 1997, the applicants asserted that Kenjirou addresses mature broccoli
237. Id.
238. It., Reissue Declaration and Power of Attorney, rec'd Nov. 7, 1997.
239. U.S. Patent No. 5,725,895, col. 21,11. 53-54 (issued Mar. 10, 1998).
240. U.S. Patent No. 5,725,895 (issued Mar. 10, 1998; reexamination certificate issued Oct. 10, 2000). The
original patent was assigned to Johns Hopkins School of Medicine, but at the time the reexamination certificate
issued, the patent was assigned to The National Institutes of Health. Id.
241. File Wrapper, U.S. Patent No. 5,725,895, Cover Sheet.
242. Id., Office Action, Sept. 3, 1996, at 1-3.
243. Id. at 2.
244. Id., Response to Restriction Requirement, Oct. 3, 1996, at 1. The nonelected claims were eventually
canceled from this application. Id., Amendment, June 18, 1997, at 1. Some of these claims appeared in U.S. Patent
Nos. 5,968,505 and 5,968,567. See infra Part IV.A.3-4 (discussing these two patents and their prosecution history).
245. File Wrapper, U.S. Patent No. 5,725,895, Office Action, Dec. 24, 1996, at 2-3.
246. Id. at 3 (citing In re Kerkhoven, 205 U.S.P.Q. 1069 (1980), and In re Gershon, 152 U.S.P.Q. 602 (1967)).
247. Id., Examiner Interview Summary Record, Mar. 11, 1997.
248. Id.
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rather than broccoli sprouts, rendering Kenjirou inapplicable to the application. 9
The other cited references, the applicants claimed, are directed to mature vegetables
and do not teach methods of using sprouts to form anticarcinogenic food products.25°
The Notice of Allowability was mailed on August 14, 1997,251 after a minor
amendment to one of the claims.252 Interestingly, the applicants requested an
expedited printing of their patent "due to [its] great commercial importance. ' 253 The
patent issued on March 10, 1998, with sixteen claims.254
On October 12, 1999, a request for reexamination of this patent was filed in
connection with a patent infringement lawsuit. 5 Several publications were cited
against the patent, but the patentability of all sixteen claims was upheld. 56
3. U.S. Patent No. 5,968,505 (Fahey et al.)
Cancer Chemoprotective Food Products
U.S. Patent No. 5,968,505 is the second of three patents originating from the
application of the '895 patent discussed in Part IV.A.2. Accordingly, the
specification of this patent is the same as that of the '895 patent. The claims in the
two patents arguably cover different subject matter. Claim I of this patent is directed
to "[a] method of increasing the chemoprotective amount of Phase 2 enzymes in a
mammal," which includes the steps of identifying and germinating seeds, harvesting
them "up to and including the 2-leaf stage," and "administering said food
product . . . . to said mammal. 257 Dependent claims are directed to particular
varieties of sprouts, and to varying amounts of other enzymes contained in said
sprouts.
The '505 patent issued from a divisional application having a filing date of
December 24, 1997.258 The divisional was filed with a preliminary amendment,
canceling all forty-seven claims and adding claims 48-71, directed to methods of
"increasing the chemoprotective amount of Phase [II] enzymes in a mammal" and
249. Id., Amendment and Request for Reconsideration, Mar. I1, 1997, at 2-5. The applicants provided a
translation for the Kenjirou reference and a declaration from their translator with this amendment.
250. Id. at 3.
251. Id., Notice of Allowability, Aug. 14, 1997.
252. Id., Examiner Interview Summary Record, Aug. 14, 1997 (noting that a claim that made reference to a
canceled claim was amended to add the language from the canceled claim).
253. id., Letter from Richard C. Peet, Sept. 22, 1997.
254. U.S. Patent No. 5,725,895 (issued Mar. 10, 1998; reexamination certificate issued Oct. 10, 2000).
255. Statement Regarding New Patents Issued and BrmccoSprouts®@, at http://www.brassica.com/press/prO0
04.htm (Oct. 21, 1999); File Wrapper, U.S. Patent No. 5,725,895, Information Disclosure Statement, Oct. 18, 1999.
256. Reexamination certificate, U.S. Patent No. B 1 5,725,895, col. 2, I. 3 (issued Oct. 10, 2000); Unique
Properties of BroccoSprouts® Validated by Patent: High-Quality Broccoli Sprouts Continue to Be Available to
Consumers, at http://www.brassica.com/press/pr0008.htm (July 25, 2000).
257. U.S. Patent No. 5,968,505, col. 21, 1. 52-col. 22, 1. 2 (issued Oct. 19, 1999).
258. U.S. Patent No. 5,968,505 (issued Oct. 19, 1999).
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"reducing the level of carcinogens in a mammal., 259 At this time, the applicants also
filed an IDS containing U.S. Patent No. 5,411,986 (Cho et al.), discussed in Part
IV.A. 1, and seventeen publication references concerning carcinogens, sprouts, and
Brassica vegetables.26°
The examiner mailed a first Office Action on September 24, 1998, rejecting all
but four of the claims for obviousness over the Cho et al. patent.2 6' According to the
examiner, Cho et al. teaches chemoprotective compounds present in certain Brassica
varieties.2 62 She further claimed that administering sprouts harvested at the two-leaf
stage would have been obvious because the compounds are taught by Cho et al. to
be chemoprotective. 263 The examiner objected to the four remaining claims because
they were dependent claims descending from a rejected independent claim; these
claims would be allowable if rewritten in independent claim form.264 The applicants
filed an IDS on January 11, 1999, disclosing another sprout reference,265 and also
filed an amendment on January 25, 1999, in response to the September Office
Action, canceling and amending various claims, adding eight new claims 266 and
supplying a declaration by one of the inventors.267 The applicants responded to the
examiner's charge of obviousness by alleging that Cho et al. does not teach that
broccoli sprouts, as opposed to mature vegetables, contain very high levels of Phase
II enzymes. 268 The same health benefit gained by eating a small quantity of sprouts
would involve eating "impractically large quantities" of mature vegetables.2 69 This
result, an unexpected health benefit, argues in favor of nonobviousness.27°
Additionally, the applicants alleged that the examiner did not make a prima facie
case for obviousness, because there is no teaching in the prior art of either increasing
the amount of Phase II enzymes or reducing the level of carcinogens in a
mammal. 27' The declaration filed with the amendment provides data and
chromatography results with respect to the amounts of Phase II enzymes in sprouts
259. See, e.g., File Wrapper, U.S. Patent No. 5,968,505, Preliminary Amendment, Dec. 24, 1997, at 1, 4
(setting forth new claims 48 and 68, each directed to such a method).
260. Id., Form PTO-1449, List of References Cited by Applicant(s), Sept. 21, 1998.
261. Id., Office Action, September 24, 1998, at 1 (rejecting claims 48-55, 58-65, and 68-71).
262. Id. at 2.
263. Id. at 2-3.
264. Id. at 3 (discussing claims 56, 57, 66 and 67).
265. Id., Information Disclosure Statement, Jan. 11, 1999.
266. Id., Amendment and Request for Reconsideration, Jan. 25, 1999, at 1-3. See id. at I (noting that claims
48-57, 68-69, and 72-78 are pending). Note also that new claim 79 is also pending, even if the practitioner failed
to include it in the list. Id. at 3 (adding new claim 79).
267. Id., Declaration of Paul Talalay, Jan. 25, 1999.
268. Id., Amendment and Request for Reconsideration, Jan. 25, 1999, at 4.
269. Id. at 5. A declaration filed by one of the inventors avers that one would need to consume such large
quantities of mature vegetables that "bowel irritation and/or flatulence" could result. Id., Declaration of Paul
Talalay, Jan. 25, 1999, at 4.
270. MPEP, supra note 25, at §§ 716.02, 716.02(a).
271. File Wrapper, U.S. Patent No. 5,968,505, Amendment and Request for Reconsideration, Jan. 25, 1999,
at 7.
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and mature vegetables.272 The applicants emphasized aspects of their method, which
provided not only high amounts of chemoprotective Phase II enzymes, but also low
amounts of Phase I enzymes, which are involved in increasing carcinogen levels.273
On February 17, 1999, the applicants and their representative met with the
examiner to discuss the application.274 According to the record, those present
discussed the results of the tumor research undertaken at Johns Hopkins and all of
the claims with respect to the Cho et al. patent.27 5 The examiner indicated that she
would favorably consider the claims regarding high amounts of Phase II enzymes
and low levels of Phase I enzymes.276 A supplemental IDS disclosing more sprout
references was filed at this time, necessitating review.277 A Notice of Allowability
was mailed on March 1, 1999, indicating allowance of all pending claims.27 8 The
patent issued on October 19, 1999.279
4. U.S. Patent No. 5,968,567 (Fahey, et al.)
Method of Preparing a Food Product from Cruciferous Sprouts
U.S. Patent No. 5,968,567, the final patent issuing from the application of the
'895 patent discussed in Part IV.A.2, issued on the same day as the '505 patent
discussed in Part IV.A.3. This application was a continuation of the previous
application, 280 and thus recites the same information in its specification. Claim 1 of
this patent is directed to -"preparing a human food product comprising cruciferous
sprouts," including the steps of identifying and germinating the particular types of
seeds, and harvesting them "up to and including the 2-leaf stage, to form a food
product comprising a plurality of said sprouts.' 28'
Unfortunately, the file wrapper for this patent was not available for public
inspection at the time this Comment was written, leaving the details of its
prosecution unexplored herein.
272. Id., Declaration of Paul Talalay, Jan. 25, 1999, Appendices.
273. Id., Amendment and Request for Reconsideration, Jan. 25, 1999, at 6-7.
274. Id., Examiner Interview Summary Record, Feb. 17, 1999.
275. Id.
276. Id.
277. Id., Information Disclosure Statement, Feb. 17, 1999.
278. Id., Notice of Allowability, Mar. 1, 1999.
279. U.S. Patent No. 5,968,505 (issued Oct. 19, 1999). A copy of the Information Disclosure Statement
regarding the Reexamination of the '895 patent and the Reexamination Certificate for that patent are included in
the File Wrapper for the '505 patent. No Request for Reexamination is present in the File Wrapper for the '505
patent.
280. U.S. Patent No. 5,968,567, col. 1, 11.4-5 (issued Oct. 19, 1999).
281. Id., col. 21, 11.54-67.
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B. The Lawsuits
The researchers at Johns Hopkins created Brassica Protection Products L.L.C.
(BPP), which was subsequently granted the exclusive license to the patents for
sprout-growing methods and chemoprotective compounds discussed in Parts IV.A.2-
4.282 Publication of the Johns Hopkins research created a flurry of excitement,
prompting sprout growers to add broccoli sprouts to their repertoire.2 83 BPP markets
BroccoSprouts®, broccoli sprouts which contain "consistently high levels of the
natural antioxidant sulforaphane GS (SGSTM). ' 284 Growers of BroccoSprouts® are
licensed by BPP and pay royalties for the privilege. 285 As of November 2000, fifteen
sprout growers were licensed to grow BroccoSprouts®.286
Unlicenced growers continued to market broccoli sprouts and were subsequently
sued by BPP and Johns Hopkins. The first suit was filed against The Sproutman,
Inc. (Sproutman), a Pennsylvania corporation, in June of 1999.287 During the
lawsuit, Sproutman filed for reexamination of the '895 patent.2 88 A consent
judgment was entered in early 2000, wherein "Sproutman was found to have
infringed upon all three of BPP's patents covering sulforaphane-rich broccoli
sprouts. '289 Approximately six months after the judgment was entered, the PTO
upheld all sixteen claims in the '895 patent.290 Since fall of 2000, BPP and Johns
Hopkins have filed similar patent infringement suits against at least six unlicenced
sprout growers across the nation for infringement of the '895, '567, and '505
patents.29' In the suit against Banner Mountain Sprouts, a Sacramento sprout
282. Cancer Protection Compound Abundant in Broccoli Sprouts, at http://hopkins.med.jhu.edu/News
Media/press/1997/SEPT/970903.HTM (Sept. 15, 1997); From Laboratory Research to Supermarket Shelves: The
History of BroccoSprouts® Broccoli Sprouts, at http://www.brassica.com/products/prhistory.htm (last modified
June 1, 2000).
283. See, e.g., Legal Battle over Broccoli Sprouts, at http://www.wfaa.com/investigatesarticle/1,1417,
3094,00.html (Sept. 26, 1999) (regarding Murray Tizer, "the Sproutman"); Celia Lamb, South Sac Firm in Broccoli
Brouhaha, SACRAMENTO Bus. J., Nov. 3,2000, at http://www.bizjournals.com/sacramento/stories/2000/11/06/story
5.html (Nov. 6, 2000) (regarding Larry Ravitz and Banner Mountain Sprouts).
284. Unique Properties of BroccoSprouts® Validated by Patent: High-Quality Broccoli Sprouts Continue
to Be Available to Customers, at http://www.brassica.com/press/pr0008.htm (July 25, 2000); Nutrition of the
Future: How a Broccoli Seed Becomes a BroccoSprout®, at http://www.brassica.com/productslprgrowing.htm (last
modified June 1, 2000).
285. International Sprout Growers Association, Should Broccoli Sprouts Be Patented?, at http:www.isga-
sprouts.org/featur2.htm (last modified Jan. 8, 2001).
286. Lamb, supra note 283.
287. Statement Regarding New Patents Issued and BroccoSprouts®, at http://www.brassica.com/press/pr
0004.htm (Oct. 21, 1999).
288. Id.
289. Brassica Protection Products Wins Patent Suit for Its Sulforaphane-Rich Broccoli Sprouts, at http:l/
www.brassica.com/press/prOO05.htm (Jan. 19, 2000).
290. Unique Properties of BroccoSprouts® Validated by Patent: High-Quality Broccoli Sprouts Continue
to Be Available to Consumers, at http://www.brassica.com/press/pr0008.htm (July 25, 2000).
291. News from the International Sprout Growers Association: We Think You Should Know, at http://isga-
sprouts.org/news.htm (last modified Jan. 25, 2001). See, e.g., Complaint for Damages and Injunctive Relief for
Patent Infringement and Demand for Jury at 6-11, Brassica Protection Products, L.L.C. et al. v. Banner Mountain
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producer, and its owner, Larry Ravitz, the complaint alleges that Banner Mountain
"has for a time past and still is infringing and/or inducing infringement" of the three
patents 292 and that Banner Mountain and Ravitz "ha[ve] been and now [are]
infringing" the three patents.293
Suing commercial sprout growers for infringement of the sprout-growing
patents is an excellent example of using patents whose infringement is difficult to
detect against the right defendants. The methods protected by the patents at issue are
easily infringed in the privacy of one's own home. Presumably, anyone may
purchase broccoli seeds at a nursery to grow in their garden, and one may choose to
harvest them when they are sprouts, rather than waiting for them to become mature
vegetables. Harvesting them at the 2-leaf stage and then eating them, or even
feeding them to your dog, is infringement. But like the instructional video market,
the sprout trade is rife with possibilities for suit. The trade may be relatively small,
but the prospect of controlling all of it, or even all of the cruciferous sprout trade,
is rather attractive.
C. The Policy in the Pudding: Desirable Results?
Two aims of intellectual property law, the growth of a rich public domain and
the encouragement and protection of new ideas, are constantly at odds.
Theoretically, protecting ideas and inventions in the patent system should not
greatly burden the public domain because only new ideas and inventions receive
protection. Nothing is taken from the public in protecting that which is new. On the
other hand, the trend of expansion in the PTO with regard to granting patents,
evidenced by patents such as those granted to Johns Hopkins, endangers the rate of
growth of the public domain and, in fact, risks taking ideas and inventions out of the
Sprouts, Inc. et al., No. S-00-2197 LKK GGH (E.D. Cal. filed Oct. 5, 2000) [hereinafter Complaint] (alleging six
counts against the sprout company and its owner).
292. Complaint, supra note 291, at 6-1I. In response, Ravitz and Banner Mountain have filed counter- and
cross-claims against BPP, Johns Hopkins, The Sholl Group, and California Sprouts for federal and state antitrust
violations, unfair trade practices, and interference with contract and prospective economic advantage. Answer of
Defendants Lawrence Ravitz, Individually and Doing Business as Banner Mountain Sprouts, Inc., a California
Corporation, to First Amended Complaint for Damages and Injunctive Relief for Patent Infringement and Demand
for Jury, Brassica Protection Products, L.L.C. et al. v. Banner Mountain Sprouts, Inc. et al., No. S-00-2197 LKK
GGH (E.D. Cal. filed Oct. 5, 2000). The Sholl Group, the exclusive marketing agent of BPP, has an interest in
California Sprouts, a sprout distributor. Id. at 30-31. Ravitz and Banner Mountain allege, inter alia, that BPP, the
Sholl Group, and California Sprouts are attempting to monopolize the entire cruciferous sprout trade by use of their
patents on cruciferous sprouts. Id. at 3 1-34. That is, the distributor, with the knowledge of BPP, has persuaded
sprout-selling establishments to cease purchase of not only broccoli sprouts, but also any other type of sprout from
Banner Mountain. Id. at 31.
293. Complaint, supra note 291, at 7-10.
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public domain.294 Thus, we are on the edge of a trend that threatens to diminish the
public domain.295
Arguably, one cannot stop ideas from germinating, nor can one stop an inventor
from inventing. New ideas and inventions will continue whether or not the
government provides for their protection. Some scholars argue that the entire patent
system should be phased out or restructured in view of new technologies.296 In that
case, new ideas and inventions would immediately enter the public domain to the
extent that other IP disciplines were unable to provide protection. A rich public
domain could easily ensue, as anything orphaned by IP statutes would immediately
belong to the public. That loss of the patent system, however, would most likely
result in harm to the consumer.
Companies may continue to survive in a patentless system by diverting the cost
of obtaining patents to a trade-secret-based scheme. The money that was used to pay
for patents would then be used to keep ideas and inventions secret. While this lateral
funding may keep costs at the same level, it may prove more expensive in the long
run because the company would be much more vulnerable when using only trade
secret law for protection. Other companies may instead choose to cut costs in
research and development, finding it a less-profitable avenue without the prospect
of patent licensing revenues. Cost-cutting in this fashion may initially benefit the
company (who receives higher profits) or the consumer (if prices are decreased), but
ultimately harms the economy through diminishing advances in technology.
The harm of allowing the PTO to run amok in granting patents is evident from
the plight of the sprout growers. By allowing researchers to patent a method of
growing sprouts simply because of the benefit of a naturally-occurring compound
in the sprout, the PTO is removing from the public the ability to grow sprouts of
vegetables of the Brassica family. The PTO either is not concerned that growing
sprouts is already part of the public domain or it intended these patents to be
construed narrowly, perhaps by limiting the scope of the patent to persons who
294. See generally Jeroen van Wilk, Broad Biotechnology Patents Hamper Innovation, BIOLOGY AND
DEVELOPMENT MONITOR, December 1995, at 15.
295. The Sonny Bono Copyright Extension Act, which lengthened the term of copyright from life of the
author plus fifty years to life plus seventy years, has had a similar effect on the public domain. Works that were
poised to enter the public domain, like Mickey Mouse, have had their entrance date postponed, which deprives the
public of something they should be in possession of, but are not. See Sonny Bono Copyright Term Extension Act,
Pub. L. No. 105-298, 112 Stat. 2827, § 102 (Oct. 27, 1998) (amending 17 U.S.C. § 302). For a potentially further-
reaching application of patent law, see generally Lester I. Yano, Comment, Protection of the Ethnobiological
Knowledge of Indigenous Peoples, 41 UCLA L. REV. 443 (1993) (arguing that patent law could be used to protect
certain types of knowledge).
296. See generally Kojo Yelpaala, Owning the Secret of Life: Biotechnology and Property Rights Revisited,
32 MCGEORGE L. REV. I 11, 186-217 (2000) (addressing the patent system with regard to biotechnology); Robert
P. Merges, As Many as Six Impossible Patents Before Breakfast: Property Rights for Business Concepts and Patent
System Reform, 14 BERKELEY TECH. L.J. 577 (1999) (exploring PTO procedures with respect to business method
patents); Lessig, supra note 90 (lamenting the growth of IP with regard to Internet-related technology). See also
Chakravarthi Raghavan, Scientists Call for Bio-Patent Ban, GMO Moratorium, at http://www.twnside.org.
sg/title/gmo-cn.htm (July 19, 1999) (addressing arguments related to the WTO and TRIPS).
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select seeds based on their Phase II enzyme-inducing potential.29 A patent this
narrow may include people who merely grow and eat sprouts for themselves for
unspecified health benefits. If the scope of the patent does not cover this type of
activity, it may only cover people who chose to grow sprouts after the results of the
Johns Hopkins research were published. Again, these benefits are due to a naturally-
occurring enzyme. The patented methods are not limited to purifying or purified
compounds, and some of the methods do not utilize the compound in any state other
than that occurring in nature.298
Essentially, Johns Hopkins' method involves choosing seeds that produce
Brassica vegetables, germinating them, harvesting them before the 2-leaf stage, and
"administering [the sprouts] to [a] mammal. 29 9 Sprouts have been available as a
food product for a number of years. 3° ° The "inventors" have not purified or altered
the compounds in the vegetables, nor have they converted them into something that
is not naturally occurring. In fact, Johns Hopkins' patents are directed to a product
of nature, namely, the glucosinates contained in Brassica vegetables.
Recall the discussion of Part II.A, regarding the traditionally unpatentable
quality of natural compounds, even when new uses or qualities were discovered.
Certainly, an unexpected benefit may be indicative of nonobviousness, but the
problem with these patents is not obviousness. The problem is the clear lack of
patentable subject matter. Compounds that occur in nature are simply not patentable
in their naturally-occurring state. A sprout is a sprout is a sprout. No special
knowledge is required to sprout any vegetable from a seed.3 ' Would the PTO have
allowed a patent on such a method for alfalfa sprouts or bean sprouts if new research
revealed that a compound they contained had miraculous properties? In view of the
Johns Hopkins patents, such a patent is conceivable. However, the true answer
should be a resounding no. Granting these patents has left the PTO in an
indefensible position, and the fact that one of them survived a reexamination is truly
absurd.
297. See, e.g., U.S. Patent No. 5,968,505, col. 21, II. 57-61 (issued Oct. 19, 1999) ("identifying seeds which
produce cruciferous sprouts .... containing high Phase 2 enzyme-inducing potential").
298. See Licensing Nature, at http://www.isga-sprouts.org/patent.htm (last modified Mar. 26,2001) (quoting
Antony Talalay, BPP's CEO, son of the Johns Hopkins researcher: "We're not doing anything to the sprouts."). See
also U.S. Patent No. 5,725,895, col. 21, I1. 52-55 (issued Mar. 10, 1998) ("A method.., to form a food product
comprising a plurality of sprouts."); U.S. Patent No. 5,968,567, col. 21, 11. 54-67 (issued Oct. 19, 1999) ("A
method ... to form a food product comprising a plurality of... sprouts.").
299. U.S. Patent No. 5,968,505, col. 22, 11. 1-2 (issued Oct. 19, 1999).
300. See, e.g., U.S. Patent No. 5,968,505, Cover Sheet (issued Oct. 19, 1999) (citing E. MUNROE, SPROUTS
TO GROW AND EAT (1974), K.C. WHYTE, THE COMPLETE SPROUTING COOKBOOK (1983), JAMES C. SCHMIDT,
GROWING SPROUTS INDOORS (1984), STEVE MEYEROWITZ, SPROUT IT! ONE WEEK FROM SEED TO SALAD (1993),
INTERNATIONAL SPROUT GROWERS ASSOCIATION, THE GOOD NEW SPROUTS RECIPE BOOK (1992)).
301. U.S. Patent No. 5,725,895, col. 10, 11. 21-24 (issued Mar. 10, 1998) ("Numerous methods for the
cultivation of sprouts are known, as ememplified by U.S. Pat. Nos. 3,733,745, 3,643,376, 3,945,148, 4,130,964,
4,292,760 or 4,086,725.").
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D. An Aside: Two Related Patents
The Johns Hopkins patents stand in contrast to two patents assigned to Amway
Corporation. U.S. Patent No. 5,686,108 concerns a method for making a vegetable
supplement from Brassica vegetables,30 2 and U.S. Patent No. 5,882,646 is directed
to the supplement itself.30 3 These patents discuss the presence of glucosinates in
Brassica vegetables and their potential for fighting disease.3 °4 They report that
enzymes present in the vegetables convert glucosinates into isothiocyanates, but are
305edmtomaiieth
also active in other, less desirable, reactions. The claimed method maximizes the
isothiocyanate content, minimizes undesirable compounds, and provides enough
additional enzymes to drive the reaction when the supplement is ingested.0 6
According to the written description, the enzyme is deactivated by steaming the
vegetable, an independent source of enzyme is added, and the resulting combination
is processed to form a tablet.30 7
The object of these patents and of the Johns Hopkins patents is to utilize the
glucosinates and the myrosinase enzymes present in Brassica vegetables.30 8 The
Amway patents use mature vegetables as a source of enzymes, while the Johns
Hopkins patents specify the use of sprouts. 309 The important difference between the
two, however, is that the inventors in the '108 patent added something. Amway's
method involves performing steps theretofore not known in nature and producing
something not known to exist in nature. The inventors in the Hopkins patents, on the
other hand, have added nothing.3 0
V. CONCLUSION
The challenges presented by new technologies will always hinder the issuance
of patents. With innovations in biotechnology and computer technology, PTO
examiners are forced to consider which innovations are truly "new," and which
innovations are merely repackaged processes and manufactures. Patent protection
is an expensive means of protection. The financial outlay is significant, as is the
302. U.S. Patent No. 5,686,108 (issued Nov. 11, 1997).
303. U.S. Patent No. 5,882,646 (issued Mar. 16, 1999).
304. Id., col. 1, 11. 12-23. The specification of the '646 patent is the same as that of the '108 patent; citations
to the '646 patent are provided.
305. Id., col. 1, 11.30-34; id., col. 4, 11. 6-13.
306. Id., col. 2, 11. 7-27.
307. Id., col. 2, I. 46-col. 3, 1. 5.
308. U.S. Patent No. 5,968,505, col. 1, 11. 17-29 (issued Oct. 19, 1999); U.S. Patent No. 5,686,108, col. 2, 11.
4-24 (issued Nov. I1, 1997); U.S. Patent No. 5,411,986, col. I, 11. 10-16 (issued May 2, 1995).
309. Compare, e.g., U.S. Patent No. 5,882,646, col. 2,11. 52-54 (issued Mar. 16, 1999) (referring to "the entire
broccoli plant" and "the broccoli floret"), with U.S. Patent No. 5,686,108, col. 9, I. 50 (issued Nov. 11, 1997)
(referring to "[a] harvested sprout according to the present invention").
310. See Licensing Nature, supra note 298 (quoting Antony Talalay, son of the Johns Hopkins researcher and
CEO of BPP: "We're not doing anything to the sprouts.").
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actual time of prosecution.3t In addition, the risk borne by those utilizing such
resources in obtaining patents of questionable value seems unjustified. Accordingly,
inventors should consider whether obtaining a patent is the best course of action.
Clearly, the current trend of the PTO in expanding the scope of patentable
subject-matter cannot continue indefinitely. Patents such as those obtained by Johns
Hopkins are arguably not new ideas and methods, but are old ideas that are no
longer available to the public, as they once were.3 12 At least one of these particular
patents was upheld by the PTO,313 but others may not fare as successfully in the
future. Inventors may currently reap the benefits of this expansion in patentable
subject matter, but they will be in a difficult spot when patents are invalidated in
years to come. As people become aware of the shrinking public domain and realize
that less is available to future inventors, judges will likely respond, ruling in favor
of reducing the scope of patentable subject matter and narrowing the interpretation
of current patents. Practitioners and inventors alike should be wary of inventions
walking that fine line of patentability.
311. See supra Part II1.F (addressing cost factors); FY 1999 USPTO ANNUAL REPORT, FY 1999 PTO
WORKLOAD TABLES, TABLE I: SUMMARY OF PATENT EXAMINING ACTIVITIES, at http://www.uspto.gov/web/offices/
com/annual/1999/99tbsl-10.pdf (last modified Aug. 10, 2000) (reporting that average prosecution time for an
application is twenty-five months).
312. See supra Part IV.C (commenting on the relationship between the Patent Office and the public domain).
313. See supra text accompanying notes 255-56 (stating that the patentability of all sixteen claims of U.S.
Patent No. 5,725,895 was upheld by the PTO in a reexamination proceeding).
